{
    "other_tests": [
        {
            "procedure_name": "Skin Fibroblast Immunoblotting",
            "date": "Not specified",
            "findings": "No pre-lamin A accumulation was detected.",
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Skin Fibroblast Immunofluorescence Staining",
            "date": "Not specified",
            "findings": "Marked nuclear morphological abnormalities were observed.",
            "changes_over_time": "The abnormal phenotype could not be rescued with inhibitors of farnesyl transferase, geranylgeranyl transferase, or histone deacetylase."
        },
        {
            "procedure_name": "Skinfold Thickness Measurements",
            "date": "Not specified",
            "findings": "Skinfold thickness at peripheral sites was below the 10th percentile, indicative of type A or partial lipodystrophy.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Plasma Insulin and Leptin Levels",
            "date": "Not specified",
            "findings": "Serum leptin level was 1.6 ng/ml; insulin level was 1.1 U/ml.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Growth Hormone Therapy",
            "date": "From ages 3 to 7 years",
            "findings": "GH therapy did not improve the short stature significantly and resistance developed at age 5 years.",
            "changes_over_time": "Initial response indicated some height increase, but growth velocity decreased significantly after developing GH resistance."
        }
    ]
}